For Juneprince, the spray volume reduction was 50% at bloom, 40% at pit hardening, and 13% at final swell. Spray drift was significantly (P less then 0.05) reduced only at bloom in the iSprayer treatment. Spray coverage was increased by 50.13 and 26.67% in the iSprayer treatment at bloom and pit hardening, respectively, but not at final swell. Our…[Read more]

The diagnostic and therapeutic potential of Maackia amurensis agglutinin (MAA) have been reported in various malignancies. Earlier, we have found that MAA specifically interacted with human non-small cell lung-cancer (NSCLC) cells and induced apoptosis in these cells. The present study was designed to identify M. amurensis leukoagglutinin (MAL-I,…[Read more]